Rexulti tablets 2mg from Otsuka Pharmaceutical contains brexpiprazole, an atypical antipsychotic indicated for the treatment of schizophrenia, as an adjunctive therapy for major depressive disorder, and agitation associated with dementia due to Alzheimer’s disease. The YJ code is 1179058F2027, with a standard of 2mg per tablet.
Rexulti tablets 2mg
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →
